Compare McKesson Corporation (MCK) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Trade Desk Inc — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Trade Desk Inc trades at $12.08 (market cap $5.83B). The key difference: McKesson Corporation is far larger — about 18.6× Trade Desk Inc's market cap, and McKesson Corporation pays a 0.4% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Trade Desk Inc for 72 Days on average.
| MCK | TTD | |
|---|---|---|
Market Cap | $108.46B | $5.83B |
Volume | 712,607 | 15,864,392 |
Sector | Health | Media |
52-Week High | $995.69 | $54.13 |
52-Week Low | $725.17 | $11.92 |
Typical Hold Time | 74 Days | 72 Days |
Enterprise Value | $115.00B | $4.78B |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
The Trade Desk (TTD) trades at $12.34, up 2.07% today but down significantly from recent highs, with a bearish technical signal. The company reported strong 2025 revenue of $2.9B and net income of $443M, though 2026 guidance suggests slowing growth. Recent news highlights competitive pressures from Amazon and Alphabet, while analyst consensus remains mixed with a $14.72 price target.
Outlook is cautious due to slowing revenue growth and intense competition, offset by strong profitability margins and market leadership in programmatic advertising. Key risks include market share erosion and execution challenges, but current valuation metrics appear attractive for long-term investors willing to withstand near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
